Introduction
Oxidatively modified low-density lipoprotein (oxLDL) emerged as a pathogenetic factor in atherosclerosis. 1 There is accumulating evidence for oxidative stress in vascular dysfunction/atherogenesis and a significant contribution of macrophages in oxLDL uptake, foam cell formation, and disease progression. 1 Considering the role of nicotinamide adenine dinucleotide phosphate (NADPH) oxidases in generating (reactive oxygen species) ROS, we recently demonstrated that NADPH oxidase is a major source of ROS in response to oxLDL with the further notion that diphenyleniodonium (DPI), a NADPH oxidase inhibitor, eliminated ROS generation in macrophages. 2 Hypoxia-inducible factor-1 (HIF-1) is a heterodimeric transcription factor composed of ␣ and ␤ subunits. 3 Although HIF-1␤ is constitutively expressed in many cell types, HIF-1␣ is present at undetectable amounts under normoxia because of rapid proteasomeal degradation and is stabilized on hypoxia. 4, 5 Following HIF-1␣/HIF-1␤ heterodimerization and translocation to the nucleus, binding to promoter-specific HRE (hypoxia response element) sites drives classical hypoxia responsive genes. 6, 7 Studies suggested that ROS provides a redox signal for hypoxic HIF-1 induction. 8 Moreover, ROS appears to regulate HIF-1 under normoxia. In some cell types, increased ROS production has been associated with HIF-1 activation by hormones, growth factors, and transition metals. 8, 9 In addition, direct exposure of cells to ROS may stabilize HIF-1␣ and promote vascular endothelial growth factor (VEGF) expression. 8, 10 Along that line cytokine-mediated regulation of HIF-1 may require a nonhypoxic but ROS-sensitive pathway. 11 Here, we showed that oxLDL provoked HIF-1␣ accumulation and HIF-1-dependent transcriptional activation in human Mono-Mac-6 (MM6) macrophages through a ROSdependent pathway.
Study design

Cell cultures
MM6 cells were grown in RPMI 1640 supplemented with 10% heatinactivated fetal calf serum, 2 mM L-glutamine, 1% nonessential amino acids, 1 mM sodium pyruvate, 9 g/mL bovine insulin and antibiotics in a humidified 5% CO 2 atmosphere at 37°C. Cell dishes at 80% to 90% confluence were exposed to native low-density lipoprotein (nLDL), oxLDL, and/or inhibitors. RCC4 cells, which constitutively express HIF-1␣ were kindly provided by Prof Ratcliffe, Wellcome Trust Centre for Human Genetics, University of Oxford, United Kingdom. 12,13 nLDL was purchased from Sigma (Taufkirchen, Germany) and oxidized as described. 2 
Western blot analysis
HIF-1␣ (antibody from Becton Dickinson, Heidelberg, Germany) as well as actin (to confirm equal protein loading) was determined by Western analysis as described. 14 
Transient transfection
MM6 cells (5 ϫ 10 5 ) were seeded in 6-cm dishes 1 day before transfection with 3 g plasmid pGL3-EPO-HRE-SV40-LUC, which harbors 3 copies of the erythropoietin hypoxia responsive element in front of the SV 40 promoter or a VEGF reporter plasmid (pGL3-1.5kbVEGFprom, obtained from Prof Maity, University of Pennsylvania Medical Center, Philadelphia), for 8 hours, using dioleoyl-1,2-diacyl-3-trimethylammonium-propane (DOTAP) for transfection according to company instructions. Thereafter, medium was changed and cells were stimulated.
RT-PCR
MM6 cells (5 ϫ 10 6 ) were incubated with or without 200 g/mL oxLDL for 5 hours. Total RNA was isolated using the peqGOLD RNAPure kit, followed by HIF-1␣ mRNA reverse transcriptase-polymerase chain reaction (RT-PCR). Primer selection was as follows: HIF-1␣, 5Ј-CTCAAAGTCGGACAGCCTCA-3Ј, 5Ј-CCCTGCAGTAGGTTTCTGCT-3Ј; actin, 5Ј-TGACGGGGTCACCCA-CACTGTGCCCATCTA-3Ј, 5Ј-CTAGAAGCATTTGCGGTCGACGATG-GAGGG-3Ј. Amplification program was as follows: 95°C, 30 seconds; 56°C, 30 seconds; 72°C, 1 minute; 20 cycles; 72°C, 10 minutes. Products were separated on 2% agarose gels and visualized with ethidium bromide.
Statistical analysis
Each experiment was performed at least 3 times, and representative data are shown. Data are presented as means Ϯ SD. The unpaired Student t test was used to evaluate the significance of differences between groups, accepting P Ͻ .05 as the level of significance.
Results and discussion
To examine the effect of oxLDL on HIF-1␣ accumulation, MM6 cells were treated with oxLDL or nLDL. As shown in Figure 1A , oxLDL dose-dependently (25-200 g/mL) induced HIF-1␣ accumulation. oxLDL was obtained by the CuSO 4 /EDTA oxidation protocol. Therefore, we ruled out that neither CuSO 4 nor EDTA at the relevant concentrations promoted HIF-1␣ accumulation ( Figure 1A) . As a positive control, to unequivocally localize HIF-1␣, we used an RCC4 protein lysate with constitutive HIF-1␣ expression ( Figure 1A) . Furthermore, we established that oxLDL but not nLDL, induced HIF-1␣ accumulation ( Figure 1B) . The most efficient response was noticed between 4 and 8 hours. Under these experimental conditions oxLDL was nontoxic (data not shown).
Reports from several groups suggested that ROS stabilizes HIF-1␣ and activates HIF-1. 8-10 Therefore, we investigated whether ROS, produced in response to oxLDL, contributed to HIF-1␣ accumulation ( Figure 1C) . N-acetyl-L-cysteine (NAC) is an antioxidant, known to decrease ROS. The addition of 3 mM NAC to MM6 cells for 2 hours prior to the stimulation with 200 g/mL oxLDL for 8 hours completely blocked HIF-1␣ accumulation. DPI inhibits oxLDL-mediated ROS formation in macrophages by blocking NADPH oxidase. 2 When cells were pretreated with 30 M DPI for 2 hours prior to oxLDL stimulation, HIF-1␣ accumulation was suppressed. Because DPI may inhibit mitochondrial complex I, we studied the effect of the structurally unrelated NADPH oxidase inhibitor AEBSF in parallel, which again prevented HIF-1␣ accumulation. The effect of nitric oxide (NO) derived from the most physiologic donor GSNO may be rationalized by the diffusion controlled interaction of O 2 Ϫ with NO, thus allowing NO to attenuate HIF-1␣ accumulation. Our experiments with NADPH oxidase inhibitors (DPI, AEBSF) and GSNO suggest that O 2 Ϫ might play a role in oxLDL-induced HIF-1␣ accumulation. Previously, it was demonstrated that mitogen-activated protein kinase (MAPK) family members such as p38 or ERK1/2 attenuated transactivation of HIF-1␣ in hypoxic cells. In MM6 cells, neither p38 (SB203580) nor ERK (PD98059) inhibitors affect oxLDL-induced HIF-1␣ accumulation ( Figure 1D ). Both inhibitors did not significantly alter HIF-1 transactivation in response to oxLDL (data not shown). Next, we examined the time-dependent disappearance of HIF-1␣ in the presence of the translational inhibitor cycloheximide ( Figure 1E ). Cells were treated with oxLDL for 4 hours followed by the subsequent addition of cycloheximide versus vehicle for 15 to 60 minutes. Cycloheximide decreased HIF-1␣ expression starting at 15 minutes, suggesting that oxLDL increased HIF-1␣ through a translational mechanism. The persistence of detectable HIF-1␣ protein 15 minutes following cycloheximide treatment could represent a delay in the onset of the cycloheximide effect but implies that the mode of action of oxLDL leaves the degradative pathway largely intact. Thus, it appeared advised to examine HIF-1␣ mRNA expression. RT-PCR ( Figure 1F ) revealed that oxLDL left HIF-1␣ mRNA levels unaltered. We then tested the ability of oxLDL to activate a HIF-1-dependent luciferase reporter gene construct, containing 3 copies of a hypoxiaresponse element derived from the human erythropoietin gene.
Treatment of MM6 cells with oxLDL resulted in significant reporter gene activation that was largely abrogated by DPI ( Figure  2A ). nLDL showed no reporter signal, whereas hypoxia elicited a luciferase activity comparable to oxLDL. Similarly, treatment of cells with oxLDL led to an increase in VEGF promoter activity ( Figure 2B ). Our results are consistent with previous studies, showing a 2-to 3-fold increase in reporter activity by hypoxia 14, 15 and further studies reporting hypoxic VEGF production in macrophages. 16 Atherosclerosis is a progressive disease and a common cause of morbidity and mortality in the Western world. Therefore, our results on HIF-1␣ accumulation by oxLDL appear of clinical relevance. It is well established that HIF-1␣ plays a major role in VEGF expression and angiogenesis 9 with the notion that VEGF mediates important alterations associated with atherogenesis and the angiogenic activity of macrophages. 16 Recent findings suggest that neovascularization within atherosclerotic plaques is a sign of advanced atherosclerosis/restenosis. 17 It is tempting to speculate that oxLDL-induced HIF-1␣ accumulation and VEGF upregulation are important in these pathophysiologic settings. A series of molecules and molecular pathways emerged that contribute to the pathogenesis and progression of both atherosclerosis and cancer. 18, 19 HIF-1 may be added to that list, considering the important tumor angiogenic role of HIF-1␣. Our observations propose a new signaling quality of oxLDL in HIF-1 accumulation and demonstrate ROS involvement. This appears of considerable importance to fully understand progression of atherosclerosis and remodeling of the arterial wall by oxLDL.
